Results 201 to 210 of about 125,690 (294)

Does Left Atrial Size and E/e' Predict Outcomes in Hypertrophic Cardiomyopathy? [PDF]

Echocardiography
Tillson B, Lord S, Eggett C.
europepmc   +1 more source

Fatal infantile mitochondrial encephalomyopathy, hypertrophic cardiomyopathy and optic atrophy associated with a homozygous OPA1 mutation [PDF]

, 2015
Ronen Spiegel, Ann Saada, Padraig J. Flannery, Florence Burté, Devorah Soiferman, Morad Khayat, Verónica Eisner, Eugene Vladovski, Robert W. Taylor, Laurence A. Bindoff, Avraham Shaag, Hanna Mandel, Ora Schuler-Furman, Stavit A. Shalev, Orly Elpeleg, Patrick Yu‐Wai‐Man   +15 more
openalex   +1 more source

Predictors of Atrial High‐Rate Episodes and Inappropriate Device Therapy in Implantable Cardioverter Defibrillators

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background Implantable cardioverter defibrillator (ICD) therapy can prevent sudden cardiac death, but poses a risk of inappropriate device therapy (IDT), which is linked to worse outcomes and reduced quality of life. On the other hand, ICDs can function as an early warning system for atrial arrhythmias.
Marthe J. Huntelaar, Luuk H. G. A. Hopman, Anne‐Lotte C. J. van der Lingen, Mischa T. Rijnierse, Michiel J. B. Kemme, Cornelis P. Allaart, Vokko P. van Halm   +6 more
wiley   +1 more source

Hypertension in Patients With Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten. [PDF]

JACC Heart Fail
Reza N, Mahmud N, Austin MA, Duqueney E, Patel P, Boakye E, Hornsby N, de Feria A, Marzolf A, Owens AT.   +9 more
europepmc   +1 more source

Cardiac biomarkers in cats [PDF]

Borgeat, K A, Connolly, D J, Fuentes, V L   +2 more
core   +1 more source

Heterologous Production of Forskolin in Tobacco (Nicotiana tabacum) via Glandular Trichome Specific Engineering and Metabolic Flux Redirection

Plant Biotechnology Journal, EarlyView.
ABSTRACT Plants are promising bioreactor for the sustainable and scalable production of high‐value natural bioactive compounds, because they can synthesise phytochemicals from CO2, light, water and minerals through their innate photosynthetic carbon assimilation machinery.
Xuan Sun, Xiuming Wu, Xun Jiang, Hongmei Huang, Aiguo Yang, Yiting Li, Zhenjun Fan, Aixia Chang, Changqing Yang   +8 more
wiley   +1 more source

Cardiopulmonary Exercise Testing for Characterization of Hypertrophic Cardiomyopathy: A Meta-Analysis. [PDF]

J Am Heart Assoc
Landsteiner I, Masri A, Saberi S, Maron MS, McGinnis SL, Griskowitz C, Newlands CE, Barriales-Villa R, Owens AT, Lewis GD.   +9 more
europepmc   +1 more source

Early left atrial reverse remodelling in patients with hypertrophic obstructive cardiomyopathy receiving transapical beating-heart septal myectomy [PDF]

Shirui Lu, Jun Zhang, Ying Zhu, Wei Zhou, Xue-Qing Cheng, Hui Wang, Yue Chen, Xiang Wei, Yani Liu   +8 more
openalex   +1 more source

Analytical Validation of a Novel Point‐Of‐Care Quantitative Immunoassay for Feline N‐Terminal Pro‐Brain Natriuretic Peptide

Veterinary Clinical Pathology, EarlyView.
ABSTRACT Background Point‐of‐care testing (POC) is widely utilized for rapid results for many different analytes. A new feline‐specific N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) quantitative assay (Vcheck V200, Bionote Inc) is currently available but has not undergone independent validation.
Emily A. Javery, Ryan C. Fries, Saki Kadotani, Leah Kruckman, Lindsey Humphries, Sumana R. Prabhakar, Michael F. Rosser   +6 more
wiley   +1 more source

Mavacamten in Symptomatic Hypertrophic Cardiomyopathy: A Paradigm Shift or Revolution? [PDF]

JACC Asia
Hung CL, Liu YW, Wu YW.
europepmc   +1 more source